- Home
- TIL vs TVGN Comparison
TIL vs TVGN Comparison
Compare TIL & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- TVGN
- Stock Information
- Founded
- TIL 2018
- TVGN 2020
- Country
- TIL United States
- TVGN United States
- Employees
- TIL N/A
- TVGN N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- TVGN Blank Checks
- Sector
- TIL Health Care
- TVGN Finance
- Exchange
- TIL Nasdaq
- TVGN Nasdaq
- Market Cap
- TIL 177.1M
- TVGN 179.0M
- IPO Year
- TIL 2021
- TVGN N/A
- Fundamental
- Price
- TIL $21.03
- TVGN $0.82
- Analyst Decision
- TIL Buy
- TVGN Strong Buy
- Analyst Count
- TIL 6
- TVGN 1
- Target Price
- TIL $120.50
- TVGN $10.00
- AVG Volume (30 Days)
- TIL 150.1K
- TVGN 476.3K
- Earning Date
- TIL 11-12-2025
- TVGN 11-18-2025
- Dividend Yield
- TIL N/A
- TVGN N/A
- EPS Growth
- TIL N/A
- TVGN N/A
- EPS
- TIL N/A
- TVGN N/A
- Revenue
- TIL N/A
- TVGN N/A
- Revenue This Year
- TIL N/A
- TVGN N/A
- Revenue Next Year
- TIL N/A
- TVGN N/A
- P/E Ratio
- TIL N/A
- TVGN N/A
- Revenue Growth
- TIL N/A
- TVGN N/A
- 52 Week Low
- TIL $10.80
- TVGN $0.26
- 52 Week High
- TIL $73.69
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- TIL 37.54
- TVGN 31.08
- Support Level
- TIL $20.11
- TVGN $0.86
- Resistance Level
- TIL $25.89
- TVGN $0.87
- Average True Range (ATR)
- TIL 2.57
- TVGN 0.05
- MACD
- TIL -0.69
- TVGN 0.00
- Stochastic Oscillator
- TIL 6.70
- TVGN 6.65
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.